Cancer Nanotechnology

BMC

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Cancer Nanotechnology is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,790 EUR. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
BMC
ISSN
1868-6958 · 1868-6966
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
1,790 EUR
Articles in DOAJ
365
Declared review time
15 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2017-07-27
Indexing
DOAJ
APC
1,790 EUR
Declared review time (DOAJ)
15 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

365

Most recent article

last month

Average review time (journal-declared via DOAJ)

15weeks

Works in OpenAlex

447

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

50

i10-index

244

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-03-17
Added to DOAJ
2017-07-27
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-09-21
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
86%
ORCID iDs in current deposits
16%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101516978
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Nanoparticle-Based Drug Delivery
  • Nanoparticle-Based Drug Delivery
  • Nanoplatforms for cancer theranostics
  • Nanoplatforms for cancer theranostics
  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
  • Graphene and Nanomaterials Applications
  • Graphene and Nanomaterials Applications
Show all subjects (50)
  • Radiation Therapy and Dosimetry
  • Radiation Therapy and Dosimetry
  • Advanced biosensing and bioanalysis techniques
  • Advanced biosensing and bioanalysis techniques
  • Advanced Nanomaterials in Catalysis
  • Advanced Nanomaterials in Catalysis
  • Extracellular vesicles in disease
  • Extracellular vesicles in disease
  • Nanoparticles: synthesis and applications
  • Nanoparticles: synthesis and applications
  • Cancer Research and Treatments
  • Cancer Research and Treatments
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • Gold and Silver Nanoparticles Synthesis and Applications
  • Gold and Silver Nanoparticles Synthesis and Applications
  • Immune cells in cancer
  • Advanced Radiotherapy Techniques
  • Advanced Radiotherapy Techniques
  • Curcumin's Biomedical Applications
  • Immunotherapy and Immune Responses
  • Ferroptosis and cancer prognosis
  • Curcumin's Biomedical Applications
  • Ferroptosis and cancer prognosis
  • Immune cells in cancer
  • Immunotherapy and Immune Responses
  • Cancer, Hypoxia, and Metabolism
  • Advancements in Transdermal Drug Delivery
  • Advancements in Transdermal Drug Delivery
  • Cancer, Hypoxia, and Metabolism
  • Nanocluster Synthesis and Applications
  • Nanocluster Synthesis and Applications
  • Cancer Immunotherapy and Biomarkers
  • Ultrasound and Hyperthermia Applications
  • Advanced Drug Delivery Systems
  • Advanced Drug Delivery Systems
  • Photoacoustic and Ultrasonic Imaging
  • Ultrasound and Hyperthermia Applications
  • Cancer Immunotherapy and Biomarkers
  • Lanthanide and Transition Metal Complexes
  • Photodynamic Therapy Research Studies
  • Photodynamic Therapy Research Studies

Keywords (DOAJ)

  • nanostructures
  • nanoscale processes
  • cancer

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: